PsyMed Ventures

We (PsyMed Ventures) are pleased to announce the release of our Environmental Toxins report, a comprehensive resource aimed at advancing knowledge and inspiring action among founders, researchers, and investors. https://buff.ly/4fpHZFE This report provides: 1️⃣ An overview of the health impacts associated with environmental toxins 2️⃣ A structured framework for identifying viable solutions 3️⃣ Insight into companies actively working on remediation 4️⃣ An analysis of emerging trends, risks, and opportunities in the field With policy shifts, advancing technology, and new scientific insights into how toxins interact with human health, the vast potential scope of this issue is coming into sharper focus. These same forces also signal that scalable solutions are on the horizon. Recent Additional Coverage: Twenty Years of Microplastic Pollution Research- (https://buff.ly/3BeaW8v) Science Environmental Neurotoxins and a Neurodegenerative Outbreak- (https://buff.ly/4hruqXO) American Journal of Medicine The Effects of Microplastics on Your Health & How to Reduce Them- (https://buff.ly/3Al9hxP) Huberman Lab They All Got Mysterious Brain Diseases. They’re Fighting to Learn Why - (https://buff.ly/3X85IDU) NY Times

We’re thrilled to welcome Brooks Leitner, MD-PhD, as a new partner at PsyMed Ventures. Brooks brings a rare blend of deep scientific expertise and clinical and entrepreneurial experience, leveling up our team as we pursue frontier opportunities in brain and mental health. Brooks has an MD-PhD from Yale University and has worked across three labs: the Perry Lab (Cellular & Molecular Physiology), the Exercise for Brain Health Lab at UMD, and the Metabolic Clinical Research Unit at The National Institutes of Health. Beyond academia, Brooks is also a founder and investor. He co-founded EpiTET Therapeutics, a biotech targeting an epigenetic regulator to address chronic diseases. On the investment side, he worked at Canaan Partners, Foresite Capital, and BrightEdge - American Cancer Society . Brooks hit the ground running—on day one, he said he had the excitement of “a dog in the pen before a race.” 

Announcing the Future Neuro Founders Workshop co-hosted by PsyMed Ventures and KdT Ventures! This virtual workshop is for scientists (PhDs, MDs, postdocs, professors) who want to build a neuroscience startup. Sign up here: https://lu.ma/xox6edul Applications open today, October 21st and close November 10th. We have an exciting lineup of entrepreneurial scientists and VCs: ⭐ Matias Serebrinsky and Brooks Leitner of PsyMed Ventures ⭐ Patrick Malone, MD PhD of KdT Ventures ⭐ Amit Etkin of Alto Neuroscience ⭐ Alexandra Sakatos of Ancilia Biosciences ⭐ Brian Pepin of Rune Labs ⭐ Tyler Benster of Reflex Tech ⭐ Ian Peikon of Cajal Neuroscience ⭐ Jacob Robinson of Motif Neurotech Participants will gain insights on topics like transitioning from academia to entrepreneurship, how to build an early-stage team, and how to partner with investors. Nominate an entrepreneurial scientist by tagging them in the comments below!

PsyMed Ventures Director of Operations Caitlin Ner is speaking on the intersection of AI & Wellness at the Los Angeles TECH WEEK by a16z. Sign up here: https://lnkd.in/gBcqMd_w

PsyMed Ventures GP Matias Serebrinsky was featured on the latest Healthtech Unveiled newsletter. Read more here: https://lnkd.in/gA3U9qNt

I started my career at a big bank. The hours and workload were intense.  It's encouraging to see the conversation shift to include mental health. I'll be speaking at the Real Summit, one of the first conferences at the intersection of finance and mental health. 40 spots left, Oct 17-18 in NYC. Hope to see you there! https://lnkd.in/eYRJFM9G

VC is not your only option. Mental and brain health startups can access non-dilutive funding sources through grants. Here are 5 grant opportunities for innovation in mental health: 1️⃣ Wellcome Trust: Grants £3 to 7 million per mental health award to fund research on digital interventions to advance early intervention in depression, anxiety and psychosis. https://lnkd.in/gtSXu_dj 2️⃣ NIH (SBIR and STTR): U.S. government grants for health startups, funding R&D and commercialization of mental health technologies. https://lnkd.in/gw6VnzZi 3️⃣ National Science Foundation (NSF) (USA): Provides grants for scientific research, including technology and neuroscience innovations relevant to mental health. https://lnkd.in/gqiWZHwY 4️⃣ Brain & Behavior Research Foundation: Provides $70,000 grants for neuroscience and mental health research, supporting early-stage discoveries and clinical innovations. https://lnkd.in/gJZbStJ4 5️⃣ Robert Wood Johnson Foundation: Focuses on health equity and innovation, including mental health projects addressing public health challenges. https://lnkd.in/g6AJhxhs We are always looking to partner with early stage startups in mental and brain health PsyMed Ventures. Feel free to apply to these grants and keep us updated!

Anxiety impacts more than 300 million people globally. Transcranial focused ultrasound (tFUS) is now improving quality of care for people with anxiety. Hear a story from a patient whose life was impacted by Sanmai's tFUS technology on the latest episode of Business Trip. Full episode here: https://lnkd.in/gMKKvsWQ

While most people associate ultrasound with prenatal imaging, this versatile technology is now making waves in an unexpected field: mental health care. Jay Sanguinetti of Sanmai shares how ultrasound works in the latest Business Trip episode. Full episode here: https://lnkd.in/gMKKvsWQ

Excited to moderate two panels on mental health bioscience at the Real Summit on Oct 17-18 in NYC. Neurotech: Energy as Medicine (Allison C. Waters, PhD) The Gut-Brain Axis and it's role in Mental Health (Christopher Reyes, PhD, Ryan Rampersaud) Early bird tix end Sept 13th, and for this week only, here's a code for 10% off ( REAL10). The conference explores the intersection of finance and mental health. https://lnkd.in/eYRJFM9G